France to offer mRNA jabs as second dose after AstraZeneca 

France to offer mRNA jabs as second dose after AstraZeneca 

FT.com

Published

Mixed-dose strategy will apply to 530,000 people under 55 following rare blood clot cases linked to the AstraZeneca vaccine

Full Article